EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikaz 4.401 - 4.600 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU REACH: List of SVHC	EU_BA Directive 2000/54/EC
Adenoviridae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Adinobacillus actinomycetemcomitans	-	-		B Bacteria and similar species	Details
Alkanes, C10-21, chloro	281-985-6	84082-38-2	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C10-26, chloro	307-451-5	97659-46-6	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C10-32, chloro	283-930-1	84776-06-7	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C12-14, chloro	287-504-6	85536-22-7	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C14-16, chloro	701-376-5	1372804-76-6	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C16-27, chloro	283-931-7	84776-07-8	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C16-35, chloro	285-195-2	85049-26-9	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, C6-18, chloro	272-924-4	68920-70-7	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alkanes, chloro	263-004-3	61788-76-9	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Alpha-hexabromocyclododecane	603-801-9	134237-50-6	PBT Persistent, Bioaccumulative and Toxic (article 57d)		Details
Aluminosilicate Refractory Ceramic Fibres	604-314-4	142844-00-6	C Carcinogenic (article 57a)		Details
Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoate	700-242-3	62037-80-3	E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)		Details
Ammonium perfluoroheptanoate	228-098-2	6130-43-4	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e) HH Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) E Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment)		Details
Ammonium perfluorohexane-1-sulphonate	269-511-6	68259-08-5	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Ancylostoma duodenale	-	-		P Parasites	Details
Angiostrongylus cantonensis	-	-		P Parasites	Details
Angiostrongylus costaricensis	-	-		P Parasites	Details
Anthracene	204-371-1	120-12-7	PBT Persistent, Bioaccumulative and Toxic (article 57d)		Details
Arcanobacterium haemolyticum	-	-		B Bacteria and similar species	Details
Arsenic acid	231-901-9	7778-39-4	C Carcinogenic (article 57a)		Details
Ascaris lumbricoides	-	-		P Parasites	Details
Ascaris suum	-	-		P Parasites	Details
Aspergillus fumigatus	-	-		F Fungi	Details
Astroviridae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Australia encephalitis	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Babesia divergens	-	-		P Parasites	Details
Babesia microti	-	-		P Parasites	Details
Bacillus anthracis	-	-		B Bacteria and similar species	Details
Bacteroides fragilis	-	-		B Bacteria and similar species	Details
Balantidium coli	-	-		P Parasites	Details
Bartonella (Rochalinea) spp.	-	-		B Bacteria and similar species	Details
Bartonella bacillifonnis	-	-		B Bacteria and similar species	Details
Bartonella quintana	-	-		B Bacteria and similar species	Details
Bebaru virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Belgrade	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Benzo[ghi]perylene	205-883-8	191-24-2	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Beta-hexabromocyclododecane	603-802-4	134237-51-7	PBT Persistent, Bioaccumulative and Toxic (article 57d)		Details
Bhanja	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Bis(2-ethylhexyl) tetrabromophthalate	247-426-5	26040-51-7	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Bis(2-ethylhexyl) tetrabromophthalate covering any of the individual isomers and/or combinations thereof	-	-	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Bis(4-chlorophenyl) sulphone	201-247-9	80-07-9	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Bis(pentabromophenyl) ether; decabromodiphenyl ether; DecaBDE	214-604-9	1163-19-5	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Bis(tributyltin)oxide; TBTO	200-268-0	56-35-9	PBT Persistent, Bioaccumulative and Toxic (article 57d)		Details
BK and JC viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Blastomyces dermatitidis	-	-		F Fungi	Details
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium (1:2)	-	90568-23-3	R Toxic for reproduction (article 57c)		Details
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)	-	125022-34-6	R Toxic for reproduction (article 57c)		Details
Bordetella bronchiseptica	-	-		B Bacteria and similar species	Details
Bordetella parapertussis	-	-		B Bacteria and similar species	Details
Bordetella pertussis	-	-		B Bacteria and similar species	Details
Boric acid (H3BO3), disodium salt	-	22454-04-2	R Toxic for reproduction (article 57c)		Details
Boric acid (H3BO3), sodium salt (1:1)	-	14890-53-0	R Toxic for reproduction (article 57c)		Details
Boric acid (H3BO3), sodium salt, hydrate	-	25747-83-5	R Toxic for reproduction (article 57c)		Details
Boric acid, sodium salt	215-604-1	1333-73-9	R Toxic for reproduction (article 57c)		Details
Borrelia burgdorferi	-	-		B Bacteria and similar species	Details
Borrelia duttonii	-	-		B Bacteria and similar species	Details
Borrelia recurrentis	-	-		B Bacteria and similar species	Details
Borrelia spp.	-	-		B Bacteria and similar species	Details
Bovine spongiform encephalopathy (BSE) and other related animal TSEs	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Brucella abortus	-	-		B Bacteria and similar species	Details
Brucella canis	-	-		B Bacteria and similar species	Details
Brucella melitensis	-	-		B Bacteria and similar species	Details
Brucella suis	-	-		B Bacteria and similar species	Details
Brugia malayi	-	-		P Parasites	Details
Brugia pahangi	-	-		P Parasites	Details
Buffalopox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Bumetrizole (UV-326)	223-445-4	3896-11-5	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Bunyamwera virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Burkholderia mallei	-	-		B Bacteria and similar species	Details
Burkholderia pseudomallei	-	-		B Bacteria and similar species	Details
Butyl 4-hydroxybenzoate	202-318-7	94-26-8	END Endocrine disrupting properties (Article 57(f) - human health)		Details
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3	208-953-6	548-62-9	C Carcinogenic (article 57a)		Details
Cadmium chloride, hydrate (2:5)	640-998-0	7790-78-5	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)		Details
Cadmium nitrate	-	-	C Carcinogenic (article 57a) M Mutagen (article 57b) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)		Details
Cadmium sulphate;cadmium sulphate show/hide Sulfuric acid, cadmium salt, hydrate (3:3:8) EC / List no: 616-572-5 \| CAS no: 7790-84-3 Sulfuric acid, cadmium salt (1:1), hydrate EC / List no: 626-360-4 \| CAS no: 15244-35-6	233-331-6	10124-36-4;31119-53-6	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)		Details
Cadmium;cadmium (non-pyrophoric);cadmium (pyrophoric)	231-152-8	7440-43-9	C Carcinogenic (article 57a) HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)		Details
Calcium arsenate	231-904-5	7778-44-1	C Carcinogenic (article 57a)		Details
California encephalitis virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Campylobacter fetus	-	-		B Bacteria and similar species	Details
Campylobacter jejuni	-	-		B Bacteria and similar species	Details
Campylobacter spp.	-	-		B Bacteria and similar species	Details
Candida albicans	-	-		F Fungi	Details
Candida tropicalis	-	-		F Fungi	Details
Capillaria philippinensis	-	-		P Parasites	Details
Capillaria spp.	-	-		P Parasites	Details
Cardiobacterium hominis	-	-		B Bacteria and similar species	Details
Central European tick-borne encephalitis virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Chikungunya virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Chlamydia pneumoniae	-	-		B Bacteria and similar species	Details
Chlamydia psittaci (avian strains)	-	-		B Bacteria and similar species	Details
Chlamydia psittaci (other strains)	-	-		B Bacteria and similar species	Details
Chlamydia trachomatis	-	-		B Bacteria and similar species	Details
Chromic acid	231-801-5	7738-94-5	C Carcinogenic (article 57a)		Details
Cladophialophora bantiana	-	-		F Fungi	Details
Clonorchis sinensis	-	-		P Parasites	Details
Clonorchisviverrini	-	-		P Parasites	Details
Clostridium botulinum	-	-		B Bacteria and similar species	Details
Clostridium perfringens	-	-		B Bacteria and similar species	Details
Clostridium spp.	-	-		B Bacteria and similar species	Details
Clostridium tetani	-	-		B Bacteria and similar species	Details
Coccidioides inunitis	-	-		F Fungi	Details
Coltivirus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Coronaviridae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Corynebacterium diphtheriae	-	-		B Bacteria and similar species	Details
Corynebacterium minutissimum	-	-		B Bacteria and similar species	Details
Corynebacterium pseudotuberculosis	-	68583-16-4		B Bacteria and similar species	Details
Corynebacterium spp.	-	-		B Bacteria and similar species	Details
Cowpox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Coxiella burnetii	-	-		B Bacteria and similar species	Details
Coxsackie viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Creutzfeldt-Jakob disease	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Crimean-Congo haemorrhagic fever	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Cryptococcus neoformans var. gattii	-	-		F Fungi	Details
Cryptococcus neoformans var. neofonnans	-	-		F Fungi	Details
Cryptosporidium parvum	-	-		P Parasites	Details
Cryptosporidium spp.	-	-		P Parasites	Details
Cyclospora cayetanensis	-	-		P Parasites	Details
Cytomegalovirus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Decamethylcyclopentasiloxane; D5	208-764-9	541-02-6	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Dengue virus type 1-4	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Di-, tri- and tetrachlorotetradecane	950-299-5	-	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Dichromic acid	236-881-5	13530-68-2	C Carcinogenic (article 57a)		Details
Dioctyltin dilaurate, stannane, dioctyl-, bis(coco acyloxy) derivs., and any other stannane, dioctyl-, bis(fatty acyloxy) derivs. wherein C12 is the predominant carbon number of the fatty acyloxy moiety show/hide Stannane, dioctyl-, bis(coco acyloxy) derivs. EC / List no: 293-901-5 \| CAS no: 91648-39-4 Dioctyltin dilaurate EC / List no: 222-883-3 \| CAS no: 3648-18-8 dioctyltin dilaurate; stannane, dioctyl-, bis(coco acyloxy) derivs. EC / List no: - \| CAS no: -	799-973-9	-	R Toxic for reproduction (article 57c)		Details
Dioxobis(stearato)trilead	235-702-8	12578-12-0	R Toxic for reproduction (article 57c)		Details
Dipetalonema streptocerca	-	-		P Parasites	Details
Diphyllobothrium latum	-	-		P Parasites	Details
Dodecamethylcyclohexasiloxane; D6	208-762-8	540-97-6	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Dracunculusmedinensis	-	-		P Parasites	Details
Eastern equine encephalomyelitis	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Ebola virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Echinococcus granulosus	-	-		P Parasites	Details
Echinococcus multilocularis	-	-		P Parasites	Details
Echinococcus vogeli	-	-		P Parasites	Details
Echo viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Edwardsiella tarda	-	-		B Bacteria and similar species	Details
Ehrlichia sennetsu	-	-		B Bacteria and similar species	Details
Ehrlichia spp.	-	-		B Bacteria and similar species	Details
Eikenella corrodens	-	-		B Bacteria and similar species	Details
Elephantpox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Emmonsia parva var. ccrescens	-	-		F Fungi	Details
Emmonsia parva var. parva	-	-		F Fungi	Details
Entamoeba histolytica	-	-		P Parasites	Details
Enterobacter aerogenes/cloacae	-	-		B Bacteria and similar species	Details
Enterobacter spp.	-	-		B Bacteria and similar species	Details
Enterococcus spp.	-	-		B Bacteria and similar species	Details
Epidermophyton floccosum	-	-		F Fungi	Details
Epstein-Barr virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Equine morbillivirus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Erysipelothrix rhusiopathiae	-	-		B Bacteria and similar species	Details
Escherichia coli (with the exception of non-pathogenic strains)	-	-		B Bacteria and similar species	Details
Escherichia coli, verocytotoxigenic strains (e.g. O157:H7 or O103)	-	-		B Bacteria and similar species	Details
Everglades virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Fasciola gigantica	-	-		P Parasites	Details
Fasciola hepatica	-	-		P Parasites	Details
Fasciolopsis buski	-	-		P Parasites	Details
Fatty acids, C16-18, lead salts	292-966-7	91031-62-8	R Toxic for reproduction (article 57c)		Details
Flavobacterium meningosepticum	-	-		B Bacteria and similar species	Details
Flexal virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Fluoranthene	205-912-4	206-44-0	PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Fluoribacter bozemanae	-	-		B Bacteria and similar species	Details
Fonsecaea compacta	-	-		F Fungi	Details
Fonsecaea pedrosoi	-	-		F Fungi	Details
Formaldehyde, oligomeric reaction products with aniline	500-036-1	25214-70-4	C Carcinogenic (article 57a)		Details
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine	300-298-5	93925-00-9	ENDE Endocrine disrupting properties (Article 57(f) - environment)		Details
Francisella tularensis (Type A)	-	-		B Bacteria and similar species	Details
Francisella tularensis (Type B)	-	-		B Bacteria and similar species	Details
Fusobacterium necrophorum	-	-		B Bacteria and similar species	Details
Gamma-hexabromocyclododecane	603-804-5	134237-52-8	PBT Persistent, Bioaccumulative and Toxic (article 57d)		Details
Gardnerella vaginalis	-	-		B Bacteria and similar species	Details
Germiston	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Gerstmann-Straussler-Scheinker syndrome	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Giardia lamblia	-	-		P Parasites	Details
Guanarito virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Haemophilus ducreyi	-	-		B Bacteria and similar species	Details
Haemophilus influenzae	-	-		B Bacteria and similar species	Details
Haemophilus spp.	-	-		B Bacteria and similar species	Details
Hantaan	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hanzalova	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hazara virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Helicobacter pylori	-	-		B Bacteria and similar species	Details
Henicosafluoroundecanoic acid	218-165-4	2058-94-8	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Hepatitis A virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis B virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis C virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis D virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis E virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis G virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis viruses not yet identified	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Heptacosafluorotetradecanoic acid	206-803-4	376-06-7	VPVB very Persistent and very Bioaccumulative (article 57e)		Details
Herpes simplex virus types 1 and 2	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Herpesvirus simiae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Herpesvirus varicella-zoster	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Histoplasma capsulatum duboisii	-	-		F Fungi	Details
Histoplasma capsulatum var. capsulatum	-	-		F Fungi	Details
Human B-lymphotropic virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human herpes virus 7	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human herpes virus 8	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human immunodeficiency viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details

Prikaz 4.401 - 4.600 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items